The Direct-to-Consumer Genetic Testing Market was valued at USD 1.71 billion in 2023 and is projected to reach USD 7.59 billion by 2032, growing at a CAGR of 17.64% during the forecast period from 2024 to 2032. This surge is largely fueled by rising consumer interest in personalized healthcare, increasing availability of at-home DNA testing kits, and...